In this large prospective cohort of non-Hispanic white postmenopausal women, we report (1) no significant differences in T2DM incidence by APOE status and (2) higher total CVD incidence in APOE4+ compared with APOE3 carriers among non-statin users. Here, APOE is linked to type 2 diabetes mellitus.